Essity AB (ESSITY-B.ST) is a leading global hygiene and health company with strong brands in tissue, personal care, and incontinence products. The company is undergoing a significant margin recovery driven by cost savings, price increases, and premium product mix. With a robust balance sheet and a dividend yield of ~3.5%, Essity offers a defensive yet growth-oriented profile.
Investment Thesis
Essity is a consumer compounder benefiting from secular trends in hygiene awareness, aging populations, and emerging market penetration. The company’s focus on innovation and sustainability positions it for long-term growth. Over the next 12 months, we expect margin expansion from restructuring and raw material cost moderation, along with market share gains in professional hygiene and incontinence care.
12-Month Catalysts
- Margin recovery from cost savings program (targeting SEK 2.5 billion annual savings by 2025) and easing pulp prices.
- Innovation pipeline: new sustainable products and digital health solutions driving premiumization.
- Emerging market expansion, particularly in Asia and Latin America, with higher growth rates.
Key Risks
- Raw material price volatility (pulp and energy) could pressure margins.
- Intense competition from private labels and other global players.
Disclaimer: This is not financial advice. Investing involves risk, including loss of principal. Please conduct your own research or consult a financial advisor.